Comment from James Roberts
AnonymousOpposeIndividual
Summary: An individual commenter urges the agency to discontinue the Commissioner’s National Priority Voucher program. They argue that the program threatens the FDA's ability to provide transparent drug reviews and prioritize safety and efficacy over political pressure or profit.
Please follow the science on drug approvals, not special interests who are more interested in maximizing profits than drug safety.
We urgently need an FDA that prioritizes the safety and efficacy of medicines, and does NOT prioritize political pressure. The FDA's national voucher prioritization program threatens the agency's ability to provide transparent review of drugs. I strongly urge you to act immediately and discontinue the Commissioner's National Priority Voucher program.